10 Moderna finance leaders
Moderna's finance group here starts with CFO Jamey Mock and Chief Accounting Officer and Controller Angelo Amico, CPA, and reaches across treasury, FP&A, commercial, international, CMC and quality, and R&D finance. Five still hold Moderna roles and five have left, three of whom are now CFOs elsewhere, so the group can speak to how Moderna's finance team was built through its scale-up and how finance partners with commercial, manufacturing and R&D leaders.
Professionals to explore
Angelo Amico, CPA
LinkedInExperience: Chief Accounting Officer and Controller · Moderna
$1,683 per 30-minute call
Chief Accounting Officer and Controller at Moderna since 2020, Angelo Amico, CPA, was a Director at CrossCountry Consulting (2018-2020), Vice President, Global Controller at Cimpress (2016-2018) and Global Divisional Controller, Urology and Pelvic Health at Boston Scientific (2014-2016). Amico fits questions on accounting, controllership and close processes at Moderna.
Is this you? Claim your profile and get paid for calls.
Christoph Brackmann
LinkedInExperience: Former SVP Finance · Moderna
$1,211 per 30-minute call
Christoph Brackmann was SVP Finance at Moderna (2019-2024), where Brackmann built and developed the finance team after the IPO and led financial governance through the company's scale-up, with FP&A among the responsibilities. Brackmann has been Chief Financial Officer at Novocure since 2025 and was Head of Finance International at Shire (2016-2018).
Is this you? Claim your profile and get paid for calls.
David Hengartner
LinkedInExperience: Former Head Finance International · Moderna
$673 per 30-minute call
As Head Finance International at Moderna (2020-2024), David Hengartner led financial strategy, operations and business partnering across EMEA, APAC and LATAM, with sales of up to $14 billion in Hengartner's words, and oversaw financial planning and analysis. Hengartner has been Chief Financial Officer at Sanecum since 2025 and held finance and treasury roles at Novartis (2014-2020).
Is this you? Claim your profile and get paid for calls.
Jamey Mock
LinkedInExperience: Chief Financial Officer · Moderna
$4,039 per 30-minute call
Jamey Mock has been Chief Financial Officer at Moderna since 2022, following SVP & CFO at PerkinElmer (2018-2022) and Vice President, Corporate Audit Staff at GE (2015-2018). Mock was also Chief Financial Officer, Subsea Systems & Drilling, GE Oil & Gas (2014-2015) and Chief Financial Officer - Engine Services at GE Aerospace (2011-2014), so questions on how Moderna's CFO sets financial priorities belong here.
Is this you? Claim your profile and get paid for calls.
Jennifer Lee
LinkedInExperience: Former Chief Accounting Officer (CAO) · Moderna
$1,683 per 30-minute call
Jennifer Lee was Chief Accounting Officer (CAO) at Moderna (2018-2020) and SVP, Chief Accounting Officer (CAO) at Lime (2021-2023). Lee was also VP Corporate Controller and Chief Accounting Officer (CAO) at Standard BioTools (2016-2018) and Director, Commercial Finance at Genentech (2010-2015), which suits questions comparing chief accounting officer work at Moderna and at other companies.
Is this you? Claim your profile and get paid for calls.
Kevan McGovern, CFA
LinkedInExperience: Head of R&D Finance · Moderna
$606 per 30-minute call
Kevan McGovern, CFA, has been Head of R&D Finance at Moderna since 2022, following Head of Finance, Alzheimer's Business Unit at Biogen (2021-2022). McGovern's other Biogen roles include Head of Finance, US Commercial Organization (2021) and Senior Director, Financial Planning and Strategy Lead - US Commercial (2020-2021), a fit for questions on R&D budgeting and portfolio funding.
Is this you? Claim your profile and get paid for calls.
Mamta Patel
LinkedInExperience: SVP, Head of Global Commercial Finance · Moderna
$1,211 per 30-minute call
Mamta Patel has been SVP, Head of Global Commercial Finance at Moderna since 2024, following CFO at Delos (2021-2024). Patel was also CFO, GE Corporate Operations at GE (2019-2021) and CFO at SUEZ (2017-2019), and describes a focus on balanced risk management and financial analytics, a fit for questions on commercial finance and risk.
Is this you? Claim your profile and get paid for calls.
Paul Baranello
LinkedInExperience: Head of Corporate FP&A and Treasury · Moderna
$673 per 30-minute call
Paul Baranello has been Head of Corporate FP&A and Treasury at Moderna since 2024, after Treasurer at Moderna (2020-2024). Baranello was Executive Director FP&A (2018-2020) and Executive Director - Treasury (2011-2018) at The Estée Lauder Companies Inc. and Senior Treasury Manager, International Operations at Amgen (2010-2011), a fit for cash, investment and planning questions.
Is this you? Claim your profile and get paid for calls.
Svetlana Sigalova
LinkedInExperience: Former Vice President, Global Commercial Finance · Moderna
$808 per 30-minute call
Svetlana Sigalova held two Moderna roles, Vice President, Corporate and Commercial Finance (2020-2023) and Vice President, Global Commercial Finance (2023-2024), and has been Chief Financial Officer at Cosmo I Building Health Confidence since 2024, leading Finance, Investor Relations and IT. Sigalova describes work across launches, rapid scale-up and the downturns that follow in biopharma.
Is this you? Claim your profile and get paid for calls.
Swapna Mehta
LinkedInExperience: Former Vice President Finance - CMC & Quality · Moderna
$673 per 30-minute call
Swapna Mehta held four Moderna finance roles: Sr Director Finance - CMC & Facilities (2020), Vice President Finance - CMC & Quality (2020-2023), Vice President - Global ERP Business Implementation (2023-2024) and Vice President - Head of INT Finance (2024-2026). Mehta has been Vice President - Head of Financial Planning & Analysis at Commonwealth Fusion Systems since 2026.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Company-wide planning and capital questions belong with Jamey Mock, and reporting and controls with Angelo Amico, CPA or Jennifer Lee. For commercial finance, Mamta Patel and Svetlana Sigalova; for treasury and corporate FP&A, Paul Baranello; for CMC, quality and ERP, Swapna Mehta; for R&D budgets, Kevan McGovern, CFA; and for international markets, David Hengartner or Christoph Brackmann.
Questions to take into the conversation
- 01How do you plan headcount and spend at a biotech when product revenue is hard to forecast a year out?
- 02How do you decide funding across R&D programs at different stages, and who in finance and R&D has the final say?
- 03What should finance own when a biotech moves manufacturing, CMC and quality into a global ERP system?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.